Fernando C. Fervenza, M.D., Ph.D.
Mayo Clinic
5
5
4
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Peter A Merkel, MD, MPH
University of Pennsylvania
Shared therapeutic areas:
Worked with same sponsors:
Peter A. Merkel, MD, MPH
University of Pennsylvania
Shared therapeutic areas:
Worked with same sponsors:
ALFONS SEGARRA, MD, PhD
Hospital Universitari Vall d´Hebron, Barcelona. Spain
Shared therapeutic areas:
JORGE ROJAS, MD
IIS Fundación Jiménez Díaz, Madrid. Spain
Shared therapeutic areas:
RIVERA FRANCISCO, MD
Hospital de Ciudad Real. Spain
Shared therapeutic areas:
GALEANO CRISTINA, MD
Hospital Universitario Ramón y Cajal, Madrid. Spain
Shared therapeutic areas:
RODRIGUEZ ANTOLINA, MD
Hospital Clínico San Carlos, Madrid. Spain
Shared therapeutic areas:
VIRGINIA CABELLO, MD
Hospital Virgen del Rocío, Sevilla. Spain
Shared therapeutic areas:
QUINTANA LUIS, MD
Hospital Clinic de Barcelona. Spain
Shared therapeutic areas:
CAO MERCEDES, MD
Hospital Universitario de A Coruña. Spain
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Rituximab in the Treatment of Idiopathic Membranous Nephropathy
CellCept in p-ANCA Vasculitis
Rituxan in Churg Strauss Syndrome With Renal Involvement
MEmbranous Nephropathy Trial Of Rituximab
All 5 trials loaded